Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 23rd October 2018
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Hysolv UK launches new swine flu vaccination
The new vaccine protects against the pandemic strain of flu pdmH1N1.
Vaccine to be used in conjunction with Respiporc FLU3

A new swine flu vaccination has been launched by Hysolv Animal Health UK.

In a press release, Hysolv said the vaccine - Respiporc FLUpanH1N1 - protects against the pandemic strain of flu pdmH1N1, which is prevalent in the British Isles.

Two 1ml doses of the inactivated vaccine can be injected intramuscularly three weeks apart to pigs over the age of 56 days, providing immunisation to the majority of animals within seven days.

Developed by IDT Biologika, the vaccine has already proved a success in Germany, where 1.7 million doses have been prescribed. Field trials revealed that vaccination not only protected against clinical signs of influenza, it also resulted in improvements in reproduction and piglet performance.

Hysolv is strongly advising that Respiporc FLUpanH1N1 is used in conjunction with its existing vaccine, Respiporc FLU3. This is because Respiporc FLU3 gives protection against three other strains of swine flu (H1N1, H1N2 and H3N2).

‘When used together, the two vaccines protect pigs against the most relevant strains in the British Isles,” the company said. 

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.